Sex differences in outcome with bevacizumab therapy: analysis of patients with advanced-stage non-small cell lung cancer treated with or without bevacizumab in combination with paclitaxel and carboplatin in the Eastern Cooperative Oncology Group Trial 4599.

Autor: Brahmer JR, Dahlberg SE, Gray RJ, Schiller JH, Perry MC, Sandler A, Johnson DH, Brahmer, Julie R, Dahlberg, Suzanne E, Gray, Robert J, Schiller, Joan H, Perry, Michael C, Sandler, Alan, Johnson, David H
Zdroj: Journal of Thoracic Oncology; 2011 Jan, Vol. 6 Issue 1, p103-108, 6p
Databáze: Complementary Index